Radiation-Chemotherapy for Oesophageal Cancer
Author Information
Author(s): P Price, PJ Hoskin, T Hutchinson, S Stenning
Primary Institution: UK Medical Research Council
Hypothesis
What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus?
Conclusion
Radiation-chemotherapy has not yet been established as standard therapy for the radical non-surgical management of carcinoma of the oesophagus in the UK.
Supporting Evidence
- The Intergroup trial showed a large difference in 5-year survival between treatment arms.
- The radiation-chemotherapy arm had a median survival of 12.5 months compared to 8.9 months for radiotherapy alone.
- Acute toxicities were more pronounced in the radiation-chemotherapy arm.
Takeaway
Doctors are trying to find the best way to treat a type of throat cancer using a mix of radiation and medicine, but they aren't sure if it's the best choice yet.
Methodology
The study involved randomized trials comparing radiotherapy alone to radiotherapy with synchronous chemotherapy.
Potential Biases
There may be biases due to differences in disease stage and type of cancer between the groups.
Limitations
The trials had small sample sizes and differences in patient demographics between treatment groups.
Participant Demographics
Patients with stage II squamous carcinoma of the oesophagus and Tl-T3 NO-N1 carcinomas.
Statistical Information
P-Value
0.16
Confidence Interval
95% confidence intervals for 2-year survival
Statistical Significance
p=0.16
Want to read the original?
Access the complete publication on the publisher's website